Clinical Diagnosis of Calcium Release Deficiency Syndrome in a Family With Sudden Cardiac Death.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42201699.
- Also identified by DOI 10.1001/jamacardio.2026.1067 and PMC identifier 13217246.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Calcium release deficiency syndrome (CRDS) is a recently described inherited arrhythmia caused by loss-of-function variants in the cardiac ryanodine receptor (RYR2). Diagnosis currently requires in vitro functional testing and availability limits diagnosis; a recently proposed burst pacing provocation test offers a potential clinical diagnostic tool, but its performance remains to be validated. To demonstrate how the novel CRDS provocation test can clinically establish the diagnosis in a family with unexplained sudden cardiac arrest and death. This case series examines a 5-generation pedigree with clinical, genetic, and functional data conducted among a large French Canadian family with an extensive history of unexplained sudden cardiac arrest and death. The study was conducted at a multidisciplinary cardiac genetics clinic at a tertiary referral center in Canada. Data were gathered and analyzed from June 2024 through March 2025. Clinical provocation with burst pacing and/or spontaneous atrial or ventricular arrhythmia detected on ambulatory monitoring. The primary outcome was diagnostic T-wave augmentation following burst pacing or spontaneous atrial or ventricular arrhythmia. In this case series, 5 RYR2 variant carriers (2 female [40%]; age range at first evaluation, 17-59 years) demonstrated diagnostic T-wave augmentation after pacing or spontaneous arrhythmia consistent with CRDS. Pause dependence was essential for diagnostic sensitivity. Functional studies of the novel RYR2-p.Glu336Gly variant confirmed that it results in loss of function. This appears to be the first such variant reported within a hot spot previously restricted to gain-of-function variants. This case series provides the first clinical application of the CRDS provocation test in a family with a history of unexplained sudden cardiac death. Findings underscore the diagnostic importance of pause dependence and highlight the need for improved risk stratification in CRDS.